Gary Myers MD (He/Him)
[Pronunciation: Doug]
Member, St Jude Children’s Research Hospital
Join to View Full Profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 901-595-8343
Dr. Myers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Gary Myers, MD, is based in Memphis, TN and specializes in pediatric hematopoietic, stem cell transplant, and cellular therapy. Dr. Myers is a member at St. Jude children’s research Hospital and the deputy chief of the clinical transplant service.
Education & Training
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2002 - 2005
University of Oklahoma Health Sciences CenterResidency, Pediatrics, 1999 - 2002- University of Oklahoma College of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2007 - Present
TN State Medical License 2025 - 2028
MO State Medical License 2008 - 2026
KS State Medical License 2008 - 2025
TX State Medical License 2005 - 2009
OK State Medical License 2000 - 2003
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of Donor Derived, Multi-virus-specific, Cytotoxic T-Lymphocytes for Relapsed/Refractory Neuroblastoma Start of enrollment: 2012 Oct 01
Publications & Presentations
PubMed
- 9 citationsFinal outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients.Sanjeet S Dadwal, Rajat Bansal, Michael W Schuster, Jean A Yared, Gary Douglas Myers
Blood Advances. 2024-09-10 - 5 citationsTisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-...Valentin Barsan, Yimei Li, Snehit Prabhu, Christina Baggott, Khanh Nguyen
Eclinicalmedicine. 2023-11-01 - 144 citationsThree-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.Theodore W Laetsch, Shannon L Maude, Susana Rives, Hidefumi Hiramatsu, Henrique Bittencourt
Journal of Clinical Oncology. 2023-03-20
Press Mentions
List of Temporary Practice Permits Granted May 5, 2020May 5th, 2020
Professional Memberships
- American Society of Blood and Marrow TransplantMember
- American Society of Gene and Cell TherapyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
